Active Substance & Generic Molecule Directory
Aspirin in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Aspirin registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:10 Prescription (MAL-A)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL16105020XZ | Cardin Orodispersible Tablet | 100mg 360mg | Prescription (MAL-A) | Y.S.P. INDUSTRIES (M) SDN. BHD. | Compare → |
| MAL11010034XZ | Hovid Aceprin-150 Tablet | 150 mg | Prescription (MAL-A) | HOVID BERHAD | Compare → |
| MAL13115223XZ | MILLISPIRIN Acetyl Salicylic Acid Soluble Tablets 300 mg (Aspirin) | 300mg 0 | Prescription (MAL-A) | UNIMED SDN. BHD. | Compare → |
| MAL19036021X | RECADIN TABLET | 100.00 mg | Prescription (MAL-A) | APEX PHARMACY MARKETING SDN. BHD. | Compare → |
| MAL19992596XCZ | Ubat Serbuk Cap Ikan Emas Aspirin 600mg/Paket | 600MG | Prescription (MAL-A) | ALPINE MEDICAL INDUSTRIES SDN. BHD. | Compare → |
| MAL20116021XCZ | VIQUPRIN TABLET | 100.00 mg | Prescription (MAL-A) | XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD. | Compare → |
| MAL19046016X | WINCARDIA Dispersible Tablet | 100 mg | Prescription (MAL-A) | KCK PHARMACEUTICAL INDUSTRIES SDN. BHD. | Compare → |
| MAL22086036XZ | WINSPIRIN Acetylsalicylic Acid Dispersible Tablet 150mg | 150.00 mg 176.00 mg | Prescription (MAL-A) | KCK PHARMACEUTICAL INDUSTRIES SDN. BHD. | Compare → |
| MAL18066046XZ | WINSPIRIN Acetylsalicylic Acid Dispersible Tablet 300mg | 300 mg | Prescription (MAL-A) | KCK PHARMACEUTICAL INDUSTRIES SDN. BHD. | Compare → |
| MAL22086035XZ | WINSPIRIN Acetylsalicylic Acid Dispersible Tablet 75mg | 75.00 mg 88.00 mg | Prescription (MAL-A) | KCK PHARMACEUTICAL INDUSTRIES SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.